Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

Go back to Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
ORAGENICS (NYSE: OGEN) Delayed: 0.52 -0.01 (1.89%)
Previous Close $0.53    52 Week High $2.12 
Open $0.53    52 Week Low $0.33 
Day High $0.53    P/E N/A 
Day Low $0.52    EPS $-0.45 
Volume 74,748